300147.SZ
Xiangxue Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 5.02
+3.51%Year over year
Reported trailing growth
- Revenue
- -10.7%
- EBITDA
- —
- EBIT
- -7.9%
- EPS
- -56.3%
- Free cash flow
- +220.5%
- Operating cash flow
- +273.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -10.0%
- EBITDA
- -32.7%
- EBIT
- -17.6%
- Net income
- -62.2%
- EPS
- -62.3%
- Free cash flow
- -24.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026